Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dyskinesia induced by phenytoin.

M A Montenegro1, A E Scotoni, F Cendes

  • 1Departamento de Neurologia, Faculdade de Ciências Médicas (FCM) da Universidade Estadual de Campinas (UNICAMP), Brasil.

Arquivos De Neuro-Psiquiatria
|August 18, 1999
PubMed
Summary

Phenytoin can cause dyskinesia, a movement disorder, even with normal drug levels. This side effect often resolves after discontinuing phenytoin, highlighting the need for careful monitoring in epilepsy patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fellowship education in epilepsy in Latin America and Africa: Results of a survey.

Epilepsy & behavior : E&B·2024
Same author

Modulating Expression of Endogenous Interleukin 1 Beta in the Acute Phase of the Pilocarpine Model of Epilepsy May Change Animal Survival.

Cellular and molecular neurobiology·2022
Same author

Inorganic Additive Improves the Survival of the Probiotic Lacticaseibacillus rhamnosus CRL1505 During Spray Drying, Rehydration, and Storage.

Current microbiology·2021
Same author

Preservation of protective capacity of hyperimmune anti-Stx2 bovine colostrum against enterohemorrhagic Escherichia coli O157:H7 pathogenicity after pasteurization and spray-drying processes.

Journal of dairy science·2021
Same author

Hippocampal Sclerosis Detection with NeuroQuant Compared with Neuroradiologists.

AJNR. American journal of neuroradiology·2020
Same author

Developmental and neurodegenerative damage in Friedreich's ataxia.

European journal of neurology·2018

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Phenytoin is a widely used antiepileptic medication.
  • Dyskinesia is a known, albeit less common, side effect of phenytoin therapy.

Observation:

  • This study describes the clinical presentation of three patients experiencing phenytoin-induced dyskinesia.
  • The patients included one adult with axial and orofacial dyskinesia and two children with choreoathetosis.

Findings:

  • Phenytoin-induced dyskinesia can manifest with varying clinical characteristics, including focal or generalized involuntary movements like choreoathetosis.
  • This side effect may occur with normal or toxic serum phenytoin levels, often in patients on polytherapy or with dosage increases.
  • Complete recovery was observed in all patients after the withdrawal of phenytoin.

Related Experiment Videos

Implications:

  • Dyskinesia as a sole sign of phenytoin toxicity can delay diagnosis and treatment.
  • Recognizing the diverse clinical features of phenytoin-induced dyskinesia is crucial for timely intervention.
  • Discontinuation of phenytoin is an effective treatment for resolving these movement disorders.